PO Box 58871
London SE15 9BE, UK
info@cedillapublishing.com
+44 (0)7794 485294


Cedilla Publishing highly commended at 2016 BMA Medical Book Awards
We are delighted to announce that our GP pain handbook, The 10-minute consultation: persistent pain, was highly commended in the primary health care category at the 2016 BMA Medical Book Awards.

The GP judging panel commented:
"Pain management is an increasingly challenging field in general practice and this [guide] brings together a lot of useful information. It is comprehensive while concise and includes a good range from the best scientific evidence through to holistic approaches. I checked some of the sections and found them to be both accurate and up-to-date. It is a good introduction to the subject."

If you are interested in purchasing copies or translation rights, please contact Sarah Findlay on +44 (0)7794 485294 or email info@cedillapublishing.com.

News Archive

Alarm as 'super malaria' spreads in South East Asia
Fri, 22 Sep 2017 11:25:10 GMT
The usual treatments are failing 60% of the time in some regions of Cambodia, scientists say.
'My baby is allergic to milk'
Sat, 23 Sep 2017 00:18:38 GMT
Tammy worries that her baby's allergy to milk protein damaged their bond.
Abortion should not be a crime, says doctors' body
Sat, 23 Sep 2017 05:16:54 GMT
The pregnancy association votes to regulate terminations in line with other medical procedures.
EU allows use of UCB?s anti-epileptic Vimpat in children
Fri, 22 Sep 2017 11:20:50 +0100
The European Commission has ruled that UCB’s anti-epileptic Vimpat can be used in children.
NICE nod for new Eylea indication
Fri, 22 Sep 2017 11:17:24 +0100
The National Institute for Health and Care Excellence (NICE) has issued a final positive recommendation for Bayer’s Eylea as a treatment for adults for the treatment of visual impairment due to myopic chorodial neovascularisation.
Sanofi?s Kevzara will be funded for NHS use
Fri, 22 Sep 2017 11:12:39 +0100
Some patients with rheumatoid arthritis living in England and Wales should get ‘routine’ NHS access to Sanofi’s Kevzara after cost regulators issued draft guidelines deeming the drug cost effective.
GPs warned over 'illegal' extraction of diabetes data
Thu, 21 Sep 2017 13:59:09 +0100
A senior BMA GP has warned that plans to extract data from practice IT systems as part of the national diabetes prevention programme could be illegal.
Practices do not have to engage with clinical peer review scheme, says GP leaders
Thu, 21 Sep 2017 15:14:37 +0100
LMC leaders have told practices they do not have to engage with a controversial new clinical peer review system.
'Enhanced' GP deal boosts practice income and patient outcomes
Wed, 20 Sep 2017 09:22:41 +0100
Midlands GP practices could earn 80,000 a year on average from a scheme that commissioners say has improved early detection of hypertension, AF and diabetes and saved money within its first 12 months.
 




 


Cedilla Publishing Limited, PO Box 58871, London SE15 9BE, United Kingdom. Tel: +44 (0)7794 485294. Email: info@cedillapublishing.com
All site content ©2006-2017 Cedilla Publishing Limited. All rights reserved. Cookies & Privacy.